Product References
In vivo antagonistic role of the Human T-Cell Leukemia Virus Type 1 regulatory proteins Tax and HBZ.
PLoS pathogens
Akkouche A,Moodad S,Hleihel R,Skayneh H,Chambeyron S,El Hajj H,Bazarbachi A
36-6300 was used in Proximity Ligation Assay (PLA), Immunocytochemistry to establish the in vivo antagonistic effect of HBZ on Tax-induced transformation and cellular effects.
Fri Jan 01 00:00:00 EST 2021
In vivo antagonistic role of the Human T-Cell Leukemia Virus Type 1 regulatory proteins Tax and HBZ.
PLoS pathogens
Akkouche A,Moodad S,Hleihel R,Skayneh H,Chambeyron S,El Hajj H,Bazarbachi A
36-6300 was used in Proximity Ligation Assay (PLA), Immunocytochemistry to establish the in vivo antagonistic effect of HBZ on Tax-induced transformation and cellular effects.
Fri Jan 01 00:00:00 EST 2021
Exosomal lncRNA UCA1 Derived From Pancreatic Stellate Cells Promotes Gemcitabine Resistance in Pancreatic Cancer via the SOCS3/EZH2 Axis.
Frontiers in oncology
Chi Y,Xin H,Liu Z
Published figure using EZH2 polyclonal antibody (Product # 36-6300) in ChIP assay
Thu Apr 28 00:00:00 EDT 2022
Exosomal lncRNA UCA1 Derived From Pancreatic Stellate Cells Promotes Gemcitabine Resistance in Pancreatic Cancer via the SOCS3/EZH2 Axis.
Frontiers in oncology
Chi Y,Xin H,Liu Z
Published figure using EZH2 polyclonal antibody (Product # 36-6300) in ChIP assay
Thu Apr 28 00:00:00 EDT 2022
Exosomal lncRNA UCA1 Derived From Pancreatic Stellate Cells Promotes Gemcitabine Resistance in Pancreatic Cancer via the SOCS3/EZH2 Axis.
Frontiers in oncology
Chi Y,Xin H,Liu Z
Published figure using EZH2 polyclonal antibody (Product # 36-6300) in ChIP assay
Thu Apr 28 00:00:00 EDT 2022
ARID1A alterations and their clinical significance in cholangiocarcinoma.
PeerJ
Namjan A,Techasen A,Loilome W,Sa-Ngaimwibool P,Jusakul A
36-6300 was used in Immunohistochemistry to find that ARID1A inactivation, by somatic mutation or by loss of expression, frequently occurs in liver fluke-related cholangiocarcinoma and is associated with its progression, providing a potential prognostic biomarker and therapeutic target.
Tue Apr 19 00:00:00 EDT 2022
ARID1A alterations and their clinical significance in cholangiocarcinoma.
PeerJ
Namjan A,Techasen A,Loilome W,Sa-Ngaimwibool P,Jusakul A
36-6300 was used in Immunohistochemistry to find that ARID1A inactivation, by somatic mutation or by loss of expression, frequently occurs in liver fluke-related cholangiocarcinoma and is associated with its progression, providing a potential prognostic biomarker and therapeutic target.
Tue Apr 19 00:00:00 EDT 2022
PDGFR-β Signaling Regulates Cardiomyocyte Proliferation and Myocardial Regeneration.
Cell reports
Yue Z,Chen J,Lian H,Pei J,Li Y,Chen X,Song S,Xia J,Zhou B,Feng J,Zhang X,Hu S,Nie Y
36-6300 was used in Immunohistochemistry-immunofluorescence to demonstrate that the PDGFR-β/EZH2 pathway is critical for promoting cardiomyocyte proliferation and heart regeneration, providing a potential target for cardiac repair.
Tue Jul 23 00:00:00 EDT 2019
The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma.
Oncotarget
Goto Y,Kurozumi A,Nohata N,Kojima S,Matsushita R,Yoshino H,Yamazaki K,Ishida Y,Ichikawa T,Naya Y,Seki N
Published figure using EZH2 polyclonal antibody (Product # 36-6300) in Western Blot
Tue Sep 13 00:00:00 EDT 2016
Repression of Igf1 expression by Ezh2 prevents basal cell differentiation in the developing lung.
Development (Cambridge, England)
Galvis LA,Holik AZ,Short KM,Pasquet J,Lun AT,Blewitt ME,Smyth IM,Ritchie ME,Asselin-Labat ML
36-6300 was used in Immunohistochemistry-immunofluorescence to explore the role of the histone methyltransferase Ezh2 during lung lineage determination.
Wed Apr 15 00:00:00 EDT 2015
Ribavirin as a tri-targeted antitumor repositioned drug.
Oncology reports
De la Cruz-Hernandez E,Medina-Franco JL,Trujillo J,Chavez-Blanco A,Dominguez-Gomez G,Perez-Cardenas E,Gonzalez-Fierro A,Taja-Chayeb L,Dueñas-Gonzalez A
36-6300 was used in western blot to investigate the therapeutic potential of ribavirin as a cancer drug
Fri May 01 00:00:00 EDT 2015
The histone chaperone Spt6 coordinates histone H3K27 demethylation and myogenesis.
The EMBO journal
Wang AH,Zare H,Mousavi K,Wang C,Moravec CE,Sirotkin HI,Ge K,Gutierrez-Cruz G,Sartorelli V
Published figure using EZH2 polyclonal antibody (Product # 36-6300) in Western Blot
Wed Apr 17 00:00:00 EDT 2013
Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
Cancer research
Natsume A,Ito M,Katsushima K,Ohka F,Hatanaka A,Shinjo K,Sato S,Takahashi S,Ishikawa Y,Takeuchi I,Shimogawa H,Uesugi M,Okano H,Kim SU,Wakabayashi T,Issa JP,Sekido Y,Kondo Y
36-6300 was used in immunohistochemistry to study the role of chromatin regulator PRC2 in epigenetic plasticity in glioblastoma
Mon Jul 15 00:00:00 EDT 2013
Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2.
Cancer research
He M,Zhang W,Bakken T,Schutten M,Toth Z,Jung JU,Gill P,Cannon M,Gao SJ
36-6300 was used in immunohistochemistry - paraffin section to demonstrate that elevated EZH2 is associated with epigenetic modifications of Kaposi sarcoma-associated herpesvirus.
Sun Jul 15 00:00:00 EDT 2012
Expression of EZH2 in renal cell carcinoma as a novel prognostic marker.
Pathology international
Lee HW,Choe M
36-6300 was used in immunohistochemistry to assess and correlate EZH2 expression in renal cell carcinoma prognosis.
Thu Nov 01 00:00:00 EDT 2012
Expression of EZH2 in renal cell carcinoma as a novel prognostic marker.
Pathology international
Lee HW,Choe M
36-6300 was used in immunohistochemistry to assess and correlate EZH2 expression in renal cell carcinoma prognosis.
Thu Nov 01 00:00:00 EDT 2012
Generation of bivalent chromatin domains during cell fate decisions.
Epigenetics & chromatin
De Gobbi M,Garrick D,Lynch M,Vernimmen D,Hughes JR,Goardon N,Luc S,Lower KM,Sloane-Stanley JA,Pina C,Soneji S,Renella R,Enver T,Taylor S,Jacobsen SE,Vyas P,Gibbons RJ,Higgs DR
36-6300 was used in ChIP assay to study the generation of bivalent chromatin domains during cell fate decisions.
Mon Jun 06 00:00:00 EDT 2011
UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis.
The EMBO journal
Seenundun S,Rampalli S,Liu QC,Aziz A,Palii C,Hong S,Blais A,Brand M,Ge K,Dilworth FJ
Wed Apr 21 00:00:00 EDT 2010
UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis.
The EMBO journal
Seenundun S,Rampalli S,Liu QC,Aziz A,Palii C,Hong S,Blais A,Brand M,Ge K,Dilworth FJ
Wed Apr 21 00:00:00 EDT 2010
Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications.
Carcinogenesis
Kwon MJ,Kim SS,Choi YL,Jung HS,Balch C,Kim SH,Song YS,Marquez VE,Nephew KP,Shin YK
Tue Jun 01 00:00:00 EDT 2010
Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications.
Carcinogenesis
Kwon MJ,Kim SS,Choi YL,Jung HS,Balch C,Kim SH,Song YS,Marquez VE,Nephew KP,Shin YK
Tue Jun 01 00:00:00 EDT 2010
Chromatin analysis of occluded genes.
Human molecular genetics
Lee JH,Gaetz J,Bugarija B,Fernandes CJ,Snyder GE,Bush EC,Lahn BT
Wed Jul 15 00:00:00 EDT 2009
Expression of stem cell markers in the human fetal kidney.
PloS one
Metsuyanim S,Harari-Steinberg O,Buzhor E,Omer D,Pode-Shakked N,Ben-Hur H,Halperin R,Schneider D,Dekel B
36-6300 was used in immunocytochemistry to identify markers of human fetal kidney stem cells
Fri Aug 21 00:00:00 EDT 2009
MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis.
The Journal of biological chemistry
Wong CF,Tellam RL
Fri Apr 11 00:00:00 EDT 2008
Dynamic changes in histone-methylation 'marks' across the locus encoding interferon-gamma during the differentiation of T helper type 2 cells.
Nature immunology
Chang S,Aune TM
Sun Jul 01 00:00:00 EDT 2007
Dynamic changes in histone-methylation 'marks' across the locus encoding interferon-gamma during the differentiation of T helper type 2 cells.
Nature immunology
Chang S,Aune TM
Sun Jul 01 00:00:00 EDT 2007
Noncoding RNA synthesis and loss of Polycomb group repression accompanies the colinear activation of the human HOXA cluster.
RNA (New York, N.Y.)
Sessa L,Breiling A,Lavorgna G,Silvestri L,Casari G,Orlando V
Thu Feb 01 00:00:00 EST 2007
